Item 1 of 1 (back to results) alpha-Neup5Ac-(2->3)-beta-D-Galp-(1->4)-[alpha-L-Fucp-(1->3)]-beta-D-GlcpNAc alpha-Neup5Ac-(2->3)-beta-D-Galp-(1->4)-[alpha-L-Fucp-(1->3)]-D-GlcpNAc in which the anomeric configuration of the reducing-end N-acetyl-beta-D-glucosamine residue is beta.

Current search: 03. Biological Effects of Specific Chemicals: epitope [CHEBI:53000] > alpha-Neup5Ac-(2->3)-beta-D-Galp-(1->4)-[alpha-L-Fucp-(1->3)]-beta-D-GlcpNAc [CHEBI:71622] × Select any link to see items in a related category. more general categories    information about this item 03. Biological Effects of Specific Chemicals  03. Biological Effects of Specific Chemicals  epitope [CHEBI:53000] (470)   alpha-Neup5Ac-(2->3)-beta-D-Galp-(1->4)-[alpha-L-Fucp-(1->3)]-beta-D-GlcpNAc [CHEBI:71622] (1) 08. Chemical Category  08. Chemical Category  main group molecular entity [CHEBI:33579] (25650)   p-block molecular entity [CHEBI:33675] (25343)   chalcogen molecular entity [CHEBI:33304] (15225)   oxygen molecular entity [CHEBI:25806] (14414)   organooxygen compound [CHEBI:36963] (11352)   carbohydrate derivative [CHEBI:63299] (2582)   oligosaccharide derivative [CHEBI:63563] (804)   amino oligosaccharide [CHEBI:22483] (607)   glucosamine oligosaccharide [CHEBI:22485] (317)   alpha-Neup5Ac-(2->3)-beta-D-Galp (1->4)-[alpha-L-Fucp-(1->3)]-D-GlcpNAc [CHEBI:61711] (2)   alpha-Neup5Ac-(2->3)-beta-D-Galp-(1->4)-[alpha-L-Fucp-(1->3)]-beta-D-GlcpNAc [CHEBI:71622] (1)  amino tetrasaccharide [CHEBI:59412] (110)   alpha-Neup5Ac-(2->3)-beta-D-Galp (1->4)-[alpha-L-Fucp-(1->3)]-D-GlcpNAc [CHEBI:61711] (2)   alpha-Neup5Ac-(2->3)-beta-D-Galp-(1->4)-[alpha-L-Fucp-(1->3)]-beta-D-GlcpNAc [CHEBI:71622] (1)  tetrasaccharide derivative [CHEBI:63567] (136)   amino tetrasaccharide [CHEBI:59412] (110)   alpha-Neup5Ac-(2->3)-beta-D-Galp (1->4)-[alpha-L-Fucp-(1->3)]-D-GlcpNAc [CHEBI:61711] (2)   alpha-Neup5Ac-(2->3)-beta-D-Galp-(1->4)-[alpha-L-Fucp-(1->3)]-beta-D-GlcpNAc [CHEBI:71622] (1)  organochalcogen compound [CHEBI:36962] (11874)   organooxygen compound [CHEBI:36963] (11352)   carbohydrate derivative [CHEBI:63299] (2582)   oligosaccharide derivative [CHEBI:63563] (804)   amino oligosaccharide [CHEBI:22483] (607)   glucosamine oligosaccharide [CHEBI:22485] (317)   alpha-Neup5Ac-(2->3)-beta-D-Galp (1->4)-[alpha-L-Fucp-(1->3)]-D-GlcpNAc [CHEBI:61711] (2)   alpha-Neup5Ac-(2->3)-beta-D-Galp-(1->4)-[alpha-L-Fucp-(1->3)]-beta-D-GlcpNAc [CHEBI:71622] (1)  amino tetrasaccharide [CHEBI:59412] (110)   alpha-Neup5Ac-(2->3)-beta-D-Galp (1->4)-[alpha-L-Fucp-(1->3)]-D-GlcpNAc [CHEBI:61711] (2)   alpha-Neup5Ac-(2->3)-beta-D-Galp-(1->4)-[alpha-L-Fucp-(1->3)]-beta-D-GlcpNAc [CHEBI:71622] (1)  tetrasaccharide derivative [CHEBI:63567] (136)   amino tetrasaccharide [CHEBI:59412] (110)   alpha-Neup5Ac-(2->3)-beta-D-Galp (1->4)-[alpha-L-Fucp-(1->3)]-D-GlcpNAc [CHEBI:61711] (2)   alpha-Neup5Ac-(2->3)-beta-D-Galp-(1->4)-[alpha-L-Fucp-(1->3)]-beta-D-GlcpNAc [CHEBI:71622] (1)  carbon group molecular entity [CHEBI:33582] (23847)   organic molecular entity [CHEBI:50860] (23769)   heteroorganic entity [CHEBI:33285] (15197)   organochalcogen compound [CHEBI:36962] (11874)   organooxygen compound [CHEBI:36963] (11352)   carbohydrate derivative [CHEBI:63299] (2582)   oligosaccharide derivative [CHEBI:63563] (804)   amino oligosaccharide [CHEBI:22483] (607)   glucosamine oligosaccharide [CHEBI:22485] (317)   alpha-Neup5Ac-(2->3)-beta-D-Galp (1->4)-[alpha-L-Fucp-(1->3)]-D-GlcpNAc [CHEBI:61711] (2)   alpha-Neup5Ac-(2->3)-beta-D-Galp-(1->4)-[alpha-L-Fucp-(1->3)]-beta-D-GlcpNAc [CHEBI:71622] (1)  amino tetrasaccharide [CHEBI:59412] (110)   alpha-Neup5Ac-(2->3)-beta-D-Galp (1->4)-[alpha-L-Fucp-(1->3)]-D-GlcpNAc [CHEBI:61711] (2)   alpha-Neup5Ac-(2->3)-beta-D-Galp-(1->4)-[alpha-L-Fucp-(1->3)]-beta-D-GlcpNAc [CHEBI:71622] (1)  tetrasaccharide derivative [CHEBI:63567] (136)   amino tetrasaccharide [CHEBI:59412] (110)   alpha-Neup5Ac-(2->3)-beta-D-Galp (1->4)-[alpha-L-Fucp-(1->3)]-D-GlcpNAc [CHEBI:61711] (2)   alpha-Neup5Ac-(2->3)-beta-D-Galp-(1->4)-[alpha-L-Fucp-(1->3)]-beta-D-GlcpNAc [CHEBI:71622] (1) ChEBI Compound Accession Identifier:   [CHEBI:71622] ChEBI Compound Description:   alpha-Neup5Ac-(2->3)-beta-D-Galp-(1->4)-[alpha-L-Fucp-(1->3)]-D-GlcpNAc in which the anomeric configuration of the reducing-end N-acetyl-beta-D-glucosamine residue is beta. ChEBI Compound Identification Number:   71622 ChEBI InChI Value:   InChI=1S/C31H52N2O23/c1-8-17(41)20(44)21(45)28(50-8)54-25-16(33-10(3)38)27(47)51-14(7-36)23(25)53-29-22(46)26(19(43)13(6-35)52-29)56-31(30(48)49)4-11(39)15(32-9(2)37)24(55-31)18(42)12(40)5-34/h8,11-29,34-36,39-47H,4-7H2,1-3H3,(H,32,37)(H,33,38)(H,48,49)/t8-,11-,12+,13+,14+,15+,16+,17+,18+,19-,20+,21-,22+,23+,24+,25+,26-,27+,28-,29-,31-/m0/s1 ChEBI InChIKey Value:   NIGUVXFURDGQKZ-UQTBNESHSA-N ChEBI Compound Name:   alpha-Neup5Ac-(2->3)-beta-D-Galp-(1->4)-[alpha-L-Fucp-(1->3)]-beta-D-GlcpNAc ChEBI SMILES Value:   [H][C@]1(O[C@@](C[C@H](O)[C@H]1NC(C)=O)(O[C@H]1[C@@H](O)[C@@H](CO)O[C@@H](O[C@@H]2[C@@H](CO)O[C@@H](O)[C@H](NC(C)=O)[C@H]2O[C@@H]2O[C@@H](C)[C@@H](O)[C@@H](O)[C@@H]2O)[C@@H]1O)C(O)=O)[C@H](O)[C@H](O)CO ChEBI Substance ID:   160713484 ChEBI URL:   ChEBI:71622 ChemSpider ID:   NS Ontomatica Chemical Accession Key (OnChAKey):   NIGUVXFURDGQKZ_UQTBNESHSA_N_000_000000 PubChem Compound ID:   44456859